メインコンテンツにスキップ
検索

Phoenix® IVIVC Toolkit™

製剤設計の最適化に向けた確かな選択

Streamline bioequivalence studies with the Phoenix IVIVC software

Changes to drug formulations or manufacturing sites can be costly and time-consuming. Regulatory agencies accept in-vitro in-vivo correlation (IVIVC) studies to support biowaivers for SUPAC changes, waive in-vivo bioequivalence for lower strengths, and address other BE requirements.

Certara’s Phoenix IVIVC Toolkit is a leading IVIVC software that provides advanced tools for IVIVC studies, helping scientists improve BE study success with fewer assumptions and better correlation between in vivo and dissolution profiles.

Minimize the number of bioavailability or bioequivalence studies

Standardize workflows with validated tools and automated features

Ensure adherence to regulatory guidelines

Advanced IVIVC software for simplified workflows and improved outcomes

The Phoenix IVIVC Toolkit simplifies and standardizes IVIVC workflows, offering a comprehensive suite of tools to streamline processes and improve outcomes. With features like dialog-guided wizards, numerical deconvolution, and custom correlation models, this software provides unparalleled support for Level A, B, and C IVIVC studies.

Built-in models for dissolution data interpolation.
Automatic estimation of Unit Impulse Response and Levy Plots.
Seamless collaboration through the Phoenix Platform.

Your data is safe with Phoenix IVIVC Toolkit

サターラでは、お客様の情報を保護することが最も重要であることを理解しています。サターラの情報セキュリティマネジメントシステム(ISMS)は、ISO 27001認証を取得しています。ISO 27001のもと、堅牢なセキュリティ管理を実施し、厳格なリスク評価を受け、継続的に改善に努めているため、安心してご利用いただけます。

デモのご相談

Discover how the Phoenix IVIVC Toolkit can revolutionize your IVIVC studies.

Accelerate drug development timelines
Minimize bioequivalence study costs
Simplify workflows with validated tools


FAQs

What is IVIVC?

IVIVC (In Vitro-In Vivo Correlation) is a predictive tool that links in vitro drug dissolution properties to in vivo pharmacokinetic responses.

What regulatory agencies support IVIVC?

Agencies like the FDA, EMA, and PMDA encourage IVIVC for solid dosage forms, particularly extended-release formulations.

How does the Phoenix IVIVC Toolkit simplify workflows?

The toolkit offers dialog-guided wizards, validated tools, and automated features to streamline IVIVC processes.

Powered by Translations.com GlobalLink Web Software